1-3 of 3
Carlos Bachier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL

Clinical Trials & Observations
Yuliya Linhares, Cesar O. Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris, Daanish Hoda, Juan C. Varela, Courtney Bellomo, Scott Cross, James Essell, Suzanne Fanning, Howard Terebelo, Habte Yimer, Jay Courtright, Jeff P. Sharman, Ana Kostic, Min Vedal, Ken Ogasawara, Ariel Avilion, Ricardo Espinola, Brenda Yuan, Bassam Mattar
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6114–6126.
https://doi.org/10.1182/bloodadvances.2024013254
Published: 2024
Includes: Supplemental data
Journal Articles

Access Barriers to Anti-CD19+ CART-Cell Therapy for NHL Across a Community Transplant and Cellular Therapy Network

Minoo Battiwalla, Michael T Tees, Ian W. Flinn, Jeremy Pantin, Jesus G. Berdeja, Tara Gregory, Michael B Maris, Vikas Bhushan, Estil Vance, M.D., John Mathews, Carlos Bachier, Paul J Shaughnessy, Aravind Ramakrishnan, Shahbaz A. Malik, Shahram Mori, Casey Martin, Rocky Billups, Betsy Blunk, Charles F LeMaistre, Navneet S Majhail
Journal: Blood Advances
Blood Adv bloodadvances.2024014171.
https://doi.org/10.1182/bloodadvances.2024014171
Published: 2024
Includes: Supplemental data
Journal Articles

A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help

Kevin J. Curran, Sarah Nikiforow, Carlos Bachier, Yen-Michael Hsu, David Maloney, Marcela V. Maus, Philip McCarthy, David Porter, Patricia Shi, Elizabeth J. Shpall, Basem William, Kara Wacker, Phyllis Warkentin, Helen E. Heslop
Journal: Blood Advances
Blood Adv (2024) 8 (4): 1053–1061.
https://doi.org/10.1182/bloodadvances.2023010401
Published: 2024